All Photos(1)


Testosterone enantate

European Pharmacopoeia (EP) Reference Standard

4-Androsten-17β-ol-3-one 17-enanthate, 17β-Hydroxy-4-androsten-3-one 17-enanthate, Testosterone enanthate, Testosterone 17β-heptanoate, (17β)-17-[(1-Oxoheptyl)oxy]androst-4-en-3-one, NSC 17591
Empirical Formula (Hill Notation):
CAS Number:
Molecular Weight:
MDL number:
PubChem Substance ID:


pharmaceutical primary standard



drug control

regulated under CDSA - not available from Sigma-Aldrich Canada


pharmaceutical (small molecule)



storage temp.


SMILES string




InChI key


Gene Information

human ... AR(367)

Looking for similar products? Visit Product Comparison Guide

General description

This product is provided as delivered and specified by the issuing Pharmacopoeia. All information provided in support of this product, including SDS and any product information leaflets have been developed and issued under the Authority of the Issuing Pharmacopoeia. For further information and support please go to the website of the issuing Pharmacopoeia.


Unit quantity: 40 mg. Subject to change. The product is delivered as supplied by the issuing Pharmacopoeia. For the current unit quantity, please visit the EDQM reference substance catalogue.


Other Notes

Sales restrictions may apply.


Exclamation markHealth hazard

Signal Word


Hazard Statements

Hazard Classifications

Acute Tox. 4 Oral - Carc. 1B - Repr. 2

Storage Class Code

6.1C - Combustible, acute toxic Cat.3 / toxic compounds or compounds which causing chronic effects



Flash Point(F)

Not applicable

Flash Point(C)

Not applicable

Certificate of Analysis

Enter Lot Number to search for Certificate of Analysis (COA).

Certificate of Origin

Enter Lot Number to search for Certificate of Origin (COO).

More Documents

Quotes and Ordering

Agnès Lacreuse et al.
Physiology & behavior, 106(2), 229-237 (2012-03-01)
The role of testosterone (T) in modulating cognitive function and emotion in men remains unclear. The paucity of animal studies has likely contributed to the slow progress in this area. In particular, studies in nonhuman primates have been lacking. Our
Hanna M King et al.
Psychoneuroendocrinology, 37(3), 396-409 (2011-08-09)
Increasing evidence in humans and other animals suggests that testosterone (T) plays an important role in modulating emotion. We previously reported that T treatment in rhesus monkeys undergoing chemically induced hypogonadism results in increased watching time of videos depicting fights
J W Kim et al.
International journal of impotence research, 25(1), 29-33 (2012-09-14)
Several studies have suggested combination therapy with testosterone supplementation in patients not responding to PDE5 inhibitors. Considering the pathophysiological basis for testosterone supplementation, the present study aims to identify whether combination therapy allows persistence of treatment effect after testosterone discontinuation.
Séverine Trabado et al.
Fertility and sterility, 95(7), 2324-2329 (2011-05-04)
To evaluate the degree of E2 deficiency in male congenital hypogonadotropic hypogonadism (CHH), and its response to different hormonal treatments. Retrospective and prospective studies. Academic institution. Untreated or treated CHH, healthy men, untreated men with Klinefelter syndrome (KS). Serum sex
Carole A Samango-Sprouse et al.
American journal of medical genetics. Part A, 161A(3), 501-508 (2013-01-25)
The effects of early androgen treatment on neurodevelopmental performance in pre-pubertal boys with 47,XXY have not been well investigated. The influence of hormones on brain development in humans suggests that a positive effect on neurodevelopmental outcome in young boys with

Our team of scientists has experience in all areas of research including Life Science, Material Science, Chemical Synthesis, Chromatography, Analytical and many others.

Contact Technical Service